Wenwen Zhou

ORCID: 0009-0002-8113-2699
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cancer Cells and Metastasis
  • Parathyroid Disorders and Treatments
  • Genetic Syndromes and Imprinting
  • SARS-CoV-2 and COVID-19 Research
  • Heterotopic Ossification and Related Conditions
  • Pain Mechanisms and Treatments
  • Botulinum Toxin and Related Neurological Disorders
  • Renal Transplantation Outcomes and Treatments
  • Computational Drug Discovery Methods
  • Protease and Inhibitor Mechanisms
  • Peptidase Inhibition and Analysis
  • Transcranial Magnetic Stimulation Studies
  • Vitamin D Research Studies
  • Hippo pathway signaling and YAP/TAZ
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Extracellular vesicles in disease
  • Tendon Structure and Treatment
  • MRI in cancer diagnosis
  • Blood properties and coagulation
  • Nanoplatforms for cancer theranostics
  • Cancer Mechanisms and Therapy
  • Radiomics and Machine Learning in Medical Imaging
  • Osteoarthritis Treatment and Mechanisms
  • Reproductive Biology and Fertility
  • Mechanisms of cancer metastasis

Chinese Academy of Medical Sciences & Peking Union Medical College
2024-2025

Chongqing Cancer Hospital
2020-2024

Chongqing University
2020-2024

The First Affiliated Hospital, Sun Yat-sen University
2012-2024

Sun Yat-sen University
2012-2024

BGI Research
2023

Shanghai Normal University
2023

BGI Group (China)
2023

Nanchang University
2021-2023

Qingdao University
2021-2022

Abstract Head and neck squamous cell carcinomas (HNSCCs) harbor a subset of cells that are CD44(+) present with malignancy radiotherapy resistance. As key regulator self-renewal, Nanog expression not only determines fate in pluripotent but also mediates tumorigenesis cancer cells; thus, we examined the role HNSCC. Three HNSCC lines, tumor xenografts, patient tumors were examined. levels significantly higher spheroids than CD44(−) spheroids, further increased when grown as to enrich for CSCs....

10.1038/s41419-020-2448-6 article EN cc-by Cell Death and Disease 2020-04-23

The recent coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome 2 (SARS-CoV-2), has exerted considerable impact on global health. To prepare for rapidly mutating viruses and the forthcoming effective therapies targeting critical stages of viral life cycle need to be developed. Viruses are dependent interaction between receptor-binding domain (RBD) Spike (S) protein (S-RBD) angiotensin-converting enzyme (ACE2) receptor efficiently establish infection...

10.3390/ijms26020678 article EN International Journal of Molecular Sciences 2025-01-15

ABSTRACT Cathepsin L (CTSL) could cleave and activate SARS-CoV-2 Spike protein to promote viral entry, making it a hopeful therapeutic target for COVID-19 prevention treatment. So CTSL inhibitors are considered be promising strategy infection. has previously been expressed in inclusion body Escherichia coli. In order prepare with high purity activity soluble active form, we transformed HEK-293T cells recombinant mammalian expression plasmid. was purified about 95%, found migrate at...

10.1093/bbb/zbae005 article EN Bioscience Biotechnology and Biochemistry 2024-01-25

Methotrexate (MTX) is widely used to treat cancers and systemic autoimmune diseases. However, it severely toxic healthy cells, especially those of the reproductive system, therefore poses a great risk patient fertility. In addition, underlying mechanism MTX-induced toxicity has not yet been fully elucidated. Here, spermatocyte cell line (GC2) was as an in vitro model system determine whether MTX induces autophagy apoptosis, elucidate role reactive oxygen species (ROS) Ca2+ these two...

10.1111/bcpt.13306 article EN Basic & Clinical Pharmacology & Toxicology 2019-08-17

Cathepsin L (CTSL), a lysosomal cysteine proteinase, is primarily dedicated to the metabolic turnover of intracellular proteins. It involved in various physiological processes and contributes pathological conditions such as viral infection, tumor invasion metastasis, inflammatory status, atherosclerosis, renal disease, diabetes, bone diseases, other ailments. The coronavirus disease 2019 (COVID-19), with its rapid global spread significant mortality, has been worldwide epidemic since late...

10.1016/j.slasd.2024.100153 article EN cc-by-nc-nd SLAS DISCOVERY 2024-03-21

Arthritis is the most common cause to lead chronic pain. Botulinum toxin type A (BoNT/A) has been widely used treat In our previous study, we confirmed anti-inflammatory and antinociceptive effects of BoNT/A in Complete Freund's Adjuvant (CFA)-induced arthritis model, but underlying mechanism was not fully elucidated. The purpose this study investigate mechanisms on using transcriptomic analysis. injected into rat ankle joint day 21 after CFA injection. von Frey hot plate tests were applied...

10.3389/fphar.2021.735075 article EN cc-by Frontiers in Pharmacology 2021-11-05

Diabetic nephropathy (DN) is one of the most prevalent complications diabetes mellitus (DM). However, there still a lack effective methods for non-invasive diagnosis DN in clinical practice. We aimed to explore biomarkers from plasma cell-free DNA as surrogate renal biopsy differentiation patients with DM. The (cfDNA) was sequenced 53 healthy individuals, DM but without DN, and 71 both DN. Multidimensional features were analyzed dissect cfDNA profile identify DN-specific features. Finally,...

10.3389/fendo.2023.1164822 article EN cc-by Frontiers in Endocrinology 2023-10-05

Abstract Background: This study aims to evaluate the therapeutic effect of intra-articular injection different doses exosomes derived from mesenchymal stem cells(MSC) and on nerve cartilage repair in a monoiodoacetate (MIA) model knee osteoarthritis(OA) rats. Methods: The pain rat was established by sodium monoiodate into joint rats, dorsal root ganglion (DRG) rats were collected for histologic analyses. For assessment, On 1 day before MIA injection, 7, 14 days after 14,28 Exosome...

10.21203/rs.3.rs-535017/v1 preprint EN cc-by Research Square (Research Square) 2021-05-24
Coming Soon ...